Internet Explorer does not cooperate well with this site. Please see below for options that work with APNA eLearning Center programs.*

4031-24: The Risks of Anticholinergic Burden in Schizophrenia Spectrum Disorders: Tips for Practice

This presentation reviews anticholinergic burden, its prevalence in schizophrenia spectrum disorder populations, and its negative impacts on cognitive ability and quality of life. Participants will gain the knowledge to identify anticholinergic side effects, understand their risks in individuals with schizophrenia spectrum disorders, and screen for them in everyday practice.

Presenter:  Jeremy Mills, DNP, PMHNP-BC

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will not be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Understand how anticholinergic side effects impact individuals diagnosed with schizophrenia spectrum disorders.

Keywords:  Anticholinergic Side Effects and Burden, Schizophrenia Spectrum Disorders, Psychopharmacology

Nursing Continuing Professional Development:
0.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to the presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Release Date:  December 12, 2024
Access to this course will end:  December 1, 2026

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.